Tag: BIO Germany e. V
Biotech has to adjust to a dry spell in terms of financing
DNA experiment In view of the declining inflow of capital, rapid successes are required in research. (Photo: imago images/Westend61) Frankfurt The collapse of the Silicon Valley Bank (SVB) and the…
Biotech companies will raise less capital in 2022
Frankfurt After record figures in the first two years of the corona pandemic, German biotech companies raised significantly less capital in 2022. A total of 921 million euros in fresh…
How Europe can build a strong biotech industry
Europe has just emerged from a crisis that has put its healthcare system to the test. The lack of autonomy in relation to research and development, the management of health…